MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 264 filers reported holding MYRIAD GENETICS INC in Q1 2019. The put-call ratio across all filers is 2.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $326,000 | +16.4% | 11,954 | +22.4% | 0.54% | +17.3% |
| Q3 2019 | $280,000 | +2.9% | 9,769 | -0.2% | 0.46% | +118.4% |
| Q2 2019 | $272,000 | +946.2% | 9,791 | +1156.9% | 0.21% | +1225.0% |
| Q1 2019 | $26,000 | +44.4% | 779 | +23.8% | 0.02% | +128.6% |
| Q4 2018 | $18,000 | -35.7% | 629 | +4.8% | 0.01% | -12.5% |
| Q3 2018 | $28,000 | +27.3% | 600 | 0.0% | 0.01% | +33.3% |
| Q2 2018 | $22,000 | – | 600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |